ArchiMed, a European private equity healthcare specialist, has acquired majority control of Deallus Consulting to help the life sciences management consultant expand its services and geographic presence, reports Private Healthcare Investor.
“We intend to accelerate the growth of Deallus by providing access to new accounts, aiding recruitment and helping to set up additional offices globally,” ArchiMed managing partner Robin Filmer-Wilson said.
Read more by visiting www.privatehealthcareinvestor.com.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: